Lowering Lp(a) vs. Normalizing
The Most Misunderstood Concept in Cholesterol and Lipoprotein(a) Management
Lowering Lp(a) vs. Normalizing: The Most Misunderstood Concept in Cholesterol and Lipoprotein(a) Management
As a medicinal chemist and author of Reverse Heart Disease, I review hundreds of LDL and Lp(a) lowering studies.
In healthy people, the liver produces normal cholesterol levels, including the genetic risk factor Lp(a) (discovered back in 1963, not new). When arterial health starts to decline, the lipid panel gets unbalanced – LDL and Lp(a) often rise, HDL sometimes falls, and triglycerides can go up.
The first stage in heart disease is artery damage due to nutrient deficiency, that triggers the liver to make unhealthy cholesterol levels. Especially LDL and Lpa levels are higher. Lpa binds on the lesions formed in the arteries as a repair mechanism
The single biggest clinical error I see is the assumption that “lowering” Lp(a) by 20‑30% with drugs like PCSK9 inhibitors solves the problem. It does not. It only slows things down for a while. Patients still get worse, still need lifelong medication, and still have repeat cardiac events.
In my view, the liver should be making normal levels on its own. But that only happens when you repair the artery. Fix the wall, and the liver calms down. The numbers take care of themselves.
So if you want to prevent lifelong suffering, you don’t just lower the number. You fix the artery.
The real distinction is between lowering a number and actually fixing the artery wall. The infographic below shows the difference – the standard drug approach (lowering the particle) versus the nutrient‑based, root‑cause approach (restoring vitamin C, lysine, and proline to rebuild collagen).
| ❌ The "Lowering" Approach (Common) | ✅ The "Fix the Artery" Approach (Root Cause) |
|---|---|
| Focus: Reduce Lp(a) number by 20-30% | Focus: Strengthen artery wall with vitamin C, lysine, proline |
| Uses PCSK9 inhibitors, statins, antisense drugs | Uses nutrients that restore collagen synthesis |
| Artery remains weak – Lp(a) still patches damage | Artery becomes strong – less need for Lp(a) to patch |
| Lowers lab numbers, but disease often progresses slowly | Addresses root cause: vitamin C deficiency + matrix failure |
| Patients stay on lifelong medication | Goal is arterial repair and reduced dependency on drugs |
Bottom line: Lowering a number is not the same as fixing the artery. The left column is standard care. The right column is what I teach in Reverse Heart Disease and on this blog.
The left side of the chart is the usual drug approach. You lower the particle count. Good. But the artery wall is still weak. Why? Because the real root cause – a long‑term, low‑grade vitamin C shortage – never got fixed. Your body cannot make strong collagen without enough vitamin C. So the artery keeps tearing, and Lp(a) keeps rushing in to patch the damage.
The right side is what I call the “repair first” approach. You give the artery what it actually needs: vitamin C, lysine, proline. Now the wall gets stronger. Lp(a) becomes less dangerous because there is nothing left to patch. That is not “lowering.” That is normalizing the whole system.
I made this chart because nobody else was drawing the distinction clearly.
The right side of the infographic (the “fix the artery” side) is not alternative medicine. It is based on the 1990s work of Rath and Pauling, plus later studies on lysine‑proline‑vitamin C combinations. By helping the artery wall repair itself, you change the conditions that make Lp(a) dangerous. You do not need to force the number down with drugs.
For the complete nutrient-based protocol and all the supporting research, please see my book, Reverse Heart Disease.
Questions about this protocol? Reach me through my contact page.
For writers, bloggers, and health professionals
You have permission to use the infographic above in your own article, podcast show notes, or social media post – under one condition: you must link back to this page (lyproc.com/lp-a-lowering-vs-normalizing/) as the source. That way your readers can get the full explanation and references.
Here is the embed code you can copy and paste into your own site:
<!– Embed Code for “Lowering vs. Normalizing Lp(a)” Infographic –><figure style=”max-width:600px; margin: 20px auto;”> <img src=”https://lyproc.com/wp-content/uploads/2026/05/Gemini_Generated_Image_84c76m84c76m84c7.png” alt=”Lowering vs Normalizing Lp(a) comparison chart by Dr. Dhotre” style=”width:100%; height:auto;”> <figcaption>Source: <a href=”https://lyproc.com/lp-a-lowering-vs-normalizing/”>Dr. Balaram Dhotre, PhD – Reverse Heart Disease</a></figcaption></figure>
For researchers or students – cite it like this
You have permission to use the infographic above in your own article, podcast show notes, or social media post – under one condition: you must link back to this page (lyproc.com/lp-a-lowering-vs-normalizing/) as the source. That way your readers can get the full explanation and references.
Here is the embed code you can copy and paste into your own site:
Dhotre, B. (2024). Lowering Lp(a) vs. Fixing the Real Problem. Retrieved from https://lyproc.com/lp-a-lowering-vs-normalizing/
That is it. No hidden agenda. I just want more people to understand the difference.
My Books
